SystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Redmond, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials. SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discover and IND-enabling stages, representing cutting-edge biologics development. We offer an opportunity for you to learn and grow while making significant contributions to the company's success. Systimmune Inc. is seeking an innovative and driven AI Scientist or Senior Scientist to contribute to our AI-driven small molecule drug design efforts. The successful candidate will work as part of our interdisciplinary team, focusing on using computational methods and machine learning to discover and design small molecules that can be developed into therapeutic drugs. This role will involve applying AI to predict molecular properties, optimize drug-like characteristics, and enhance the lead development process. The ideal candidate will have experience in computational chemistry, molecular modeling, and the application of AI and machine learning techniques to small molecule drug discovery. This individual will collaborate closely with chemists, biologists, and computational scientists to drive drug development from discovery through preclinical stages.